CARSON CITY, Nevada - April 24, 2021
Recognizes the importance of the multiple systems in place in the U.S. to monitor the safety of COVID-19 vaccines
Today, the Western States Scientific Safety Review Workgroup completed its review of the federal process and has concluded that the use of the Johnson & Johnson (Janssen Biotech) COVID-19 vaccine should resume in the Western States.
On Friday, the U.S. Food and Drug Administration (FDA) lifted its pause on the use of the Johnson & Johnson vaccine, following a review by a federal vaccine safety review panel. The Workgroup further recommended that vaccine information fact sheets be culturally and linguistically appropriate, and available in multiple languages at an accessible reading level to inform conversations between health care providers and vaccine recipients.
Statement from Nevada Governor Steve Sisolak:
"The benefits of the one-shot Janssen vaccine clearly outweigh the risks - that’s what the short pause allowed leading scientific minds to study and review, at both the federal and state level. As one of many Nevadans who gladly took this vaccine when it was offered to me, I look forward to resuming the use of the vaccine in our State, along with the Moderna and Pfizer products. Every shot in an arm puts Nevada one step closer to recovery."
Statement from California Governor Gavin Newsom:
“After additional review, analysis and scrutiny, experts have concluded the Johnson & Johnson vaccine is safe, effective, and will protect you against the COVID-19 virus. To date, about a million Californians have already received this vaccine—including myself. I encourage all Californians to trust the science, getting vaccinated is the best way to protect ourselves and our loved ones and end the pandemic.”
Statement from Washington Governor Jay Inslee:
“The benefits of the J&J vaccine outweigh the risks associated with it. We want to keep as many people free from COVID and out of the hospital as possible, and the J&J vaccine will help us get through this pandemic. I encourage people to get whatever vaccine is available to them. If you have questions or concerns, consult a provider to help answer questions you have.”